Citation Impact
Citing Papers
Abscopal Effects of Radiotherapy Are Enhanced by Combined Immunostimulatory mAbs and Are Dependent on CD8 T Cells and Crosspriming
2016
Therapeutic Immune Modulation against Solid Cancers with Intratumoral Poly-ICLC: A Pilot Trial
2018
Arid5a Promotes Immune Evasion by Augmenting Tryptophan Metabolism and Chemokine Expression
2021 StandoutNobel
Viral Vectors in Gene Therapy: Where Do We Stand in 2023?
2023
Colorectal cancer statistics, 2023
2023 Standout
Progress and challenges towards targeted delivery of cancer therapeutics
2018 Standout
Platelet factor 4–induced T H 1-T reg polarization suppresses antitumor immunity
2024 StandoutScienceNobel
Phosphorylation of eukaryotic initiation factor-2α (eIF2α) in autophagy
2020
The tumour microenvironment harbours ontogenically distinct dendritic cell populations with opposing effects on tumour immunity
2016
The history and advances in cancer immunotherapy: understanding the characteristics of tumor-infiltrating immune cells and their therapeutic implications
2020 Standout
Screening Libraries to Discover Molecular Design Principles for the Targeted Delivery of mRNA with One-Component Ionizable Amphiphilic Janus Dendrimers Derived from Plant Phenolic Acids
2023 StandoutNobel
Dendritic cells in cancer immunology and immunotherapy
2019 Standout
Elements of cancer immunity and the cancer–immune set point
2017 StandoutNature
Safety and clinical activity of pembrolizumab for treatment of recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-012): an open-label, multicentre, phase 1b trial
2016 Standout
The role of myeloid cells in cancer therapies
2016
Chronic inflammation in the etiology of disease across the life span
2019 Standout
Approaches to treat immune hot, altered and cold tumours with combination immunotherapies
2019 Standout
The biology and management of non-small cell lung cancer
2018 StandoutNature
Lipid nanoparticle chemistry determines how nucleoside base modifications alter mRNA delivery
2021 StandoutNobel
Direct Activation of STING in the Tumor Microenvironment Leads to Potent and Systemic Tumor Regression and Immunity
2015 Standout
Hallmarks of aging: An expanding universe
2023 Standout
Ferroptosis turns 10: Emerging mechanisms, physiological functions, and therapeutic applications
2022 Standout
Trial Watch: Immunostimulation with Toll-like receptor agonists in cancer therapy
2015
Highly efficient CD4+ T cell targeting and genetic recombination using engineered CD4+ cell-homing mRNA-LNPs
2021 StandoutNobel
COVID-19 vaccine development and a potential nanomaterial path forward
2020
Natural and therapy-induced immunosurveillance in breast cancer
2015
Immunogenic cell death in cancer and infectious disease
2016 Standout
The immune contexture in cancer prognosis and treatment
2017 Standout
The molecular machinery of regulated cell death
2019 Standout
Biological Functions of Autophagy Genes: A Disease Perspective
2019 Standout
Peptide-based materials for cancer immunotherapy
2019
Delivery technologies for cancer immunotherapy
2019 Standout
Turbocharging vaccines: emerging adjuvants for dendritic cell based therapeutic cancer vaccines
2017
Updates on immunotherapy for colorectal cancer
2018
Intratumoral modulation of the inducible co-stimulator ICOS by recombinant oncolytic virus promotes systemic anti-tumour immunity
2017 StandoutNobel
Inflammation and tumor progression: signaling pathways and targeted intervention
2021 Standout
Nanomaterials for cancer immunotherapy
2017
Overview of hepatitis B viral replication and genetic variability
2016
Immunological Effects of Conventional Chemotherapy and Targeted Anticancer Agents
2015
Going viral with cancer immunotherapy
2014
Biomaterials for vaccine-based cancer immunotherapy
2018
Targeting apoptosis in cancer therapy
2020 Standout
CAR T‐cell immunotherapy: The path from the by‐road to the freeway?
2015
Oncolytic Immunotherapy: Dying the Right Way is a Key to Eliciting Potent Antitumor Immunity
2014
Peroxidation of n-3 and n-6 polyunsaturated fatty acids in the acidic tumor environment leads to ferroptosis-mediated anticancer effects
2021
Light‐Controlled Histone Deacetylase (HDAC) Inhibitors: Towards Photopharmacological Chemotherapy
2015 StandoutNobel
Tumorigenic and Immunosuppressive Effects of Endoplasmic Reticulum Stress in Cancer
2017
mRNA vaccine with unmodified uridine induces robust type I interferon-dependent anti-tumor immunity in a melanoma model
2022 StandoutNobel
Broadening horizons: the role of ferroptosis in cancer
2021 Standout
Mechanism-driven biomarkers to guide immune checkpoint blockade in cancer therapy
2016 Standout
Glycogen synthase kinase 3β inhibitors prevent hepatitis C virus release/assembly through perturbation of lipid metabolism
2017 StandoutNobel
The evolving tumor microenvironment: From cancer initiation to metastatic outgrowth
2023 Standout
The Emerging Hallmarks of Cancer Metabolism
2016 Standout
Macrophages as regulators of tumour immunity and immunotherapy
2019 Standout
Integrating Next-Generation Dendritic Cell Vaccines into the Current Cancer Immunotherapy Landscape
2017
Tumour-associated macrophages as treatment targets in oncology
2017 Standout
Histone deacetylases and their inhibitors in cancer, neurological diseases and immune disorders
2014
Activation of Nrf2 Signaling Augments Vesicular Stomatitis Virus Oncolysis via Autophagy-Driven Suppression of Antiviral Immunity
2017
Immunogenic cell stress and death
2022
Therapeutic targeting of the NRF2 and KEAP1 partnership in chronic diseases
2019 Standout
The immune contexture and Immunoscore in cancer prognosis and therapeutic efficacy
2020
Engineering HSV-1 Vectors for Gene Therapy
2014
Therapeutic targeting of macrophages enhances chemotherapy efficacy by unleashing type I interferon response
2019
Personalized Dendritic Cell Vaccines—Recent Breakthroughs and Encouraging Clinical Results
2019
Trial watch: IDO inhibitors in cancer therapy
2014
Potentiation of immunomodulatory antibody therapy with oncolytic viruses for treatment of cancer
2014
Combinatorial Strategies for the Induction of Immunogenic Cell Death
2015
Nutrition, inflammation and cancer
2017
Effects of amino acid substitutions in hepatitis B virus surface protein on virion secretion, antigenicity, HBsAg and viral DNA
2016 StandoutNobel
Inflammageing: chronic inflammation in ageing, cardiovascular disease, and frailty
2018 Standout
The Journey of in vivo Virus Engineered Dendritic Cells From Bench to Bedside: A Bumpy Road
2018
Tumor-infiltrating regulatory T cells as targets of cancer immunotherapy
2023 StandoutNobel
Lipoprotein profiles in SCID/uPA mice transplanted with human hepatocytes become human-like and correlate with HCV infection success
2010
Management of glioblastoma: State of the art and future directions
2020 Standout
EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection
2017 Standout
Potent STING activation stimulates immunogenic cell death to enhance antitumor immunity in neuroblastoma
2020
Lipid Nanoparticles Delivering Constitutively Active STING mRNA to Stimulate Antitumor Immunity
2022 StandoutNobel
In Vivo mRNA CAR T Cell Engineering via Targeted Ionizable Lipid Nanoparticles with Extrahepatic Tropism
2023 StandoutNobel
Pro-necrotic molecules impact local immunosurveillance in human breast cancer
2017
Advances in RNAi therapeutic delivery to leukocytes using lipid nanoparticles
2016
Trial Watch: Immunostimulation with recombinant cytokines for cancer therapy
2018
Oncolytic Adenovirus Complexes Coated with Lipids and Calcium Phosphate for Cancer Gene Therapy
2016
Nanotechnology for Multimodal Synergistic Cancer Therapy
2017 Standout
Human serum leads to differentiation of human hepatoma cells, restoration of very-low-density lipoprotein secretion, and a 1000-fold increase in HCV Japanese fulminant hepatitis type 1 titers
2013 StandoutNobel
Spermidine in health and disease
2018 StandoutScience
Autophagy in metabolism and quality control: opposing, complementary or interlinked functions?
2021
Ultra-processed food consumption and risk of colorectal cancer precursors: results from 3 prospective cohorts
2022
Prevention of hepatitis C virus infection using a broad cross‐neutralizing monoclonal antibody (AR4A) and epigallocatechin gallate
2015 StandoutNobel
Evolution of Oncolytic Viruses: Novel Strategies for Cancer Treatment
2013
Cancer treatment and survivorship statistics, 2019
2019 Standout
Reactive Oxygen Species (ROS)-Based Nanomedicine
2019 Standout
Combination therapy strategies for improving PD‐1 blockade efficacy: a new era in cancer immunotherapy
2017 StandoutNobel
Single-Molecule Sequencing Reveals Complex Genome Variation of Hepatitis B Virus during 15 Years of Chronic Infection following Liver Transplantation
2016
IGF1 receptor inhibition amplifies the effects of cancer drugs by autophagy and immune-dependent mechanisms
2021
Hyper-Progressive Disease: The Potential Role and Consequences of T-Regulatory Cells Foiling Anti-PD-1 Cancer Immunotherapy
2020 StandoutNobel
Works of Jonathan Pol being referenced
Combining Oncolytic HSV-1 with Immunogenic Cell Death-Inducing Drug Mitoxantrone Breaks Cancer Immune Tolerance and Improves Therapeutic Efficacy
2013
HDAC Inhibition Suppresses Primary Immune Responses, Enhances Secondary Immune Responses, and Abrogates Autoimmunity During Tumor Immunotherapy
2013
Trial Watch: Immunogenic cell death inducers for anticancer chemotherapy
2015
Expression of Defective Hepatitis B Virus Particles Derived from Singly Spliced RNA Is Related to Liver Disease
2008
Trial watch: Tumor-targeting monoclonal antibodies for oncological indications
2015
Gold Standard Assessment of Immunogenic Cell Death in Oncological Mouse Models
2018
Prospective comparison of Abbott RealTime HBV DNA and Versant HBV DNA 3.0 assays for hepatitis B DNA quantitation: Impact on HBV genotype monitoring
2008
Trial Watch: Radioimmunotherapy for oncological indications
2014
Trial Watch: Peptide-based anticancer vaccines
2015
Maraba Virus as a Potent Oncolytic Vaccine Vector
2013
Trial Watch—Oncolytic viruses and cancer therapy
2015
Trial Watch:
2014
Trial watch: Dendritic cell-based anticancer therapy
2014
Oncolytic vesicular stomatitis virus quantitatively and qualitatively improves primary CD8+T-cell responses to anticancer vaccines
2013
First oncolytic virus approved for melanoma immunotherapy
2015
Immunogenic HSV-mediated Oncolysis Shapes the Antitumor Immune Response and Contributes to Therapeutic Efficacy
2013
Delivery of viral-vectored vaccines by B cells represents a novel strategy to accelerate CD8+ T-cell recall responses
2013
Autophagy induction by thiostrepton improves the efficacy of immunogenic chemotherapy
2020
Trial watch: DNA-based vaccines for oncological indications
2017
Inhibition of transcription by dactinomycin reveals a new characteristic of immunogenic cell stress
2020
A synergistic triad of chemotherapy, immune checkpoint inhibitors, and caloric restriction mimetics eradicates tumors in mice
2019
Metabolic effects of fasting on human and mouse blood in vivo
2017
Trial watch: dietary interventions for cancer therapy
2019
Effects of interleukin-2 in immunostimulation and immunosuppression
2019
Trial watch: Peptide-based vaccines in anticancer therapy
2018
The Molecular Hallmarks of the Serrated Pathway in Colorectal Cancer
2019